| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c22c6d06e5563aee18cc3c610cfa6180 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
| filingDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47aaabde55a634159d1b09c8cbfe7250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7878cbf45920268e5d9b06c2c8163760
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98360551c668ff8d16df14dbbd265518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a91dd816a300128a23549d9e6d95344d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f94c8fad038b1e6cb5e23297a3ca588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470a68586efa359b531fedc11fdbc2f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c45af64b6b4734a4ba51e00f785df4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf5b0a271651e6fe7f60e0b7fd24da8 |
| publicationDate |
2008-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2008008582-A |
| titleOfInvention |
MIMETIC PEPTIDES OF CARBOHYDRATES AND THEIR EMPLOYMENT IN PHARMACEUTICAL FORMULATIONS. |
| abstract |
The present invention is related to the pharmaceutical industry and biotechnology, more specifically to vaccine antigens applied against bacterial, viral, cancerous, or other diseases; development of formulations capable of protecting or elevating the protective spectrum of existing vaccines and extending it against different pathogens, using carbohydrates formed by repeated units of (? 2-8) N-substituted neuraminic acid as a target for the immune response; Peptides were isolated and identified as molecular mimetics of the capsular polysaccharide of Neisseria meningitidis serogroup B, consisting of repeated units of (? -28) N-acetylated neuraminic acid; the immunogenicity of the peptides was evaluated in animal biomodels, demonstrating their value as antibody inducing antigens capable of specifically recognizing N. meningitidis of serogroup B and showing bactericidal activity against it; The formulations resulting from this invention are applicable in the pharmaceutical industry as vaccine formulations for human use. |
| priorityDate |
2005-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |